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Abstract: In this paper, a Mamdani-type fuzzy controller is proposed as the controller part of an artificial pancreas.
The controller is optimized with the artificial bee colony optimization algorithm. The glucose–insulin regulatory system,
based on a nonlinear diﬀerential model in the presence of delay, is used both for virtual patient and healthy person
data. The main target of the controller is to mimic a blood glucose concentration profile of the healthy person with
exogenous insulin infusion. Simulations are performed to assess the control function in terms of tracking the blood
glucose concentration profile of the healthy person and minimizing errors. To show robustness, a group of three tests are
implemented. These tests include unusual glucose intake, sensor noise, and uncertainty in the clearance rate parameter.
The simulation results demonstrate that the adopted method is more eﬀective than similar studies in the literature.
Key words: Artificial bee colony algorithm, artificial pancreas, fuzzy control, Type 1 diabetes mellitus

1. Introduction
Diabetes mellitus (DM) is described as chronic hyperglycemia, caused by failure of the pancreas. The International Diabetes Federation reports that in 2013 there were almost 382 million patients with DM [1]. By 2035,
the number of patients is expected to reach 592 million. In Type 1 diabetes mellitus (T1DM), the beta cells that
produce insulin are destroyed by the immune system. This type is most common in children and adolescents. On
the other hand, more than 90% of diabetic patients have Type 2 DM (T2DM). In T2DM, the insulin produced
by the pancreas does not function properly due to resistance to the insulin. Especially for patients with T1DM,
exogenous insulin should be infused at an appropriate rate in order to keep blood glucose concentration (BGC)
in a normoglycemic range (70–180 mg/dL [2]). To infuse exogenous insulin at an appropriate rate, a closed-loop
control system has been widely used [2–4], as illustrated in Figure 1. The closed-loop control system is also
known as the artificial pancreas, which consists of a glucose sensor or continuous glucose monitor (CGM), a
controller, and an insulin pump. The CGM signals are transmitted to the controller. The controller then uses
a control algorithm to send the data of the proper insulin dose to the insulin pump.
Recently, studies on modeling the glucose–insulin regulatory system of the patient with T1DM have
increased. These models have great importance in terms of understanding the system. Several of these models,
such as Bergman’s minimal model, the Hovorka model, and UVa/Padova’s model, are very common [5–7].
Thanks to advances in modeling, control theory, and biomedical engineering, several control algorithms
have been proposed to keep the BGC of the patients with T1DM in the normoglycemic range. These algorithms
are mainly based on classical controllers [3,8,9], adaptive controllers [10], or robust controllers [4]. Although
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Figure 1. Block diagram of the closed-loop glucose control system [3,15].

these controllers have a good performance in simulation studies, they are unable to cope with the uncertainty
and nonlinearity of biological systems, such as that of the glucose–insulin regulatory system [11,12].
Fuzzy logic (FL) is a promising approach to solving such complex control problems. FL allows the
capture of valuable information about the behavior of the controlled variable, which can be a good guide that
helps realize the artificial pancreas. FL is insensitive to the variability of system parameters and can overcome
inter- and intrapatient variability [12]. In [13–16], fuzzy logic controllers (FLCs) showed relatively successful
results in keeping the BGC of the patients with T1DM in a normoglycemic range. However, they have certain
disadvantages [17,18]:
• Most depend on Bergman’s minimal model, which may result in less eﬃcient treatment, because the
oscillatory nature of the glucose–insulin system is not accurately presented by the minimal model.
• The main purpose of these controllers is to keep BGC at a predetermined reference value. Therefore, the
oscillatory nature of the glucose–insulin dynamics in healthy individuals is not imitated.
• In [13–15], the fuzzy rules and fuzzy membership functions (MFs) of the controllers are based on expert
knowledge. Thus, it is quite diﬃcult to get optimal control via tuning the MFs with a trial and error
method.
Considering these shortcomings, an optimized fuzzy-PID controller based on the nonlinear delay diﬀerential
model of glucose–insulin is designed for regulating the BGC of patients with T1DM. The nonlinear delay
diﬀerential model (i.e. the reference model) shows the glucose status in healthy individuals with scheduled
insulin infusion. The purpose of the optimized controller is to mimic the glucose oscillation of the reference
model. In order to achieve this, artificial bee colony (ABC) optimization algorithm is employed to select the
optimum parameter values of the MFs of all fuzzy variables and the weighting factors.
2. Materials
2.1. Mathematical model of the glucose–insulin regulatory system
This study considers the glucose–insulin regulatory system, based on the nonlinear diﬀerential model in the
presence of delay [19]. The dynamics of the model were studied both quantitatively and qualitatively. The
insulin therapies were modeled to simulate the pancreatic insulin secretion of a healthy person. In [19], it was
clearly demonstrated that the blood insulin concentration (BIC) profiles of the patient with T1DM are similar
to those of the healthy person by modeling the external insulin therapies. The glucose and insulin dynamics
under external insulin therapies for patients with T1DM are described by
dG
= Gin (t) − f2 (G(t)) − f3 (G(t))f4 (I(t − τ3 )) + f5 (I(t − τ2 ))
dt

(1)
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dI
= Iin (t) − di (I(t)),
dt

(2)

where I(t) and G(t) represent BIC and BGC at time t ≥ 0, respectively. Iin (t) stands for the exogenous
insulin infusion rate (in terms of mU/min) and Gin (t) denotes the glucose intake rate (in terms of mg/dL.min),
which are given in Eqs. (3) and (4), respectively.
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(4)

45 ≤ t ≤ 240(min).

f2 (G(t)), given in Eq. (5), is the insulin-independent utilization of glucose, mostly by brain and nerve cells. The
insulin-dependent utilization of the glucose is denoted by f3 (G(t)) f4 (I(t)). The corresponding formulations of
these functions are presented in Eqs. (6) and (7). τ3 > 0 is the time delay for insulin-dependent utilization by
cells. f5 (I(t)) represents the glucose production function controlled by the insulin concentration, as in Eq. (8).
τ2 > 0 stands for the time delay for hepatic glucose production. The insulin clearance rate is a constant and is
denoted by di > 0.
f2 (G(t)) = Ub (1 − exp(−G/(C2 Vg )))

(5)

f3 (G(t)) = G/(C3 Vg )

(6)

f4 (I(t)) = U0 + (Um − U0 )/(1 + exp(−β ln(I/C4 (1/Vi + 1/(0.2ti )))))

(7)

f5 (I(t)) = Rg /(1 + exp(α(I/Vp − C5 ))),

(8)

where Ub , C2 , Vg , C3 , U0 , Um , β , C4 , Vi , ti , Rg , α , Vp , and C5 are fixed parameters, determined by
experimental measurements taken from healthy individuals [19]. These parameters are given in Table 1.
2.2. Brief explanation of the ABC algorithm
The ABC algorithm, proposed by Karaboga [20], is a swarm-based global optimization algorithm that imitates
the intelligent foraging behavior of honey bees. This algorithm stands out with its simplicity and robustness,
and is one of the recently proposed algorithms [21].
The position of a food source is considered as a solution in the ABC algorithm. ABC is composed of
onlooker, scout, and employed bees. The classification of the bees is determined by the selection method of
the food source. The number of solutions in the population is equal to the population of either employed or
174
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Table 1. Parameters of the functions in Eqs. (5)–(8) [19].

Parameters
Ub
C2
Vg
C3
U0
Um
β

Units
mg.min−1
mg.L−1
L
mg.L−1
mg.min−1
mg.min−1
–

Values
72
144
10
1000
40
940
1.77

Parameters
C4
Vi
ti
Rg
α
Vp
C5

Units
m.U.L−1
L
min
mg.min−1
L.m.U−1
l
m.U.L−1

Values
80
11
100
180
0.29
3
26

onlooker bees. Employed bees provide information to the onlooker bees about the quality of the food source
site. Thanks to this information, onlooker bees select profitable food source regions, whereas scout bees explore
new rich food sources [22]. A detailed description of the algorithm, including its main steps and mathematical
infrastructure, can be found in [20–22].
Recently, the ABC algorithm has been widely used for optimization problems. Compared to particle
swarm optimization (PSO) and the genetic algorithm (GA), ABC has the ability to get out of a local minimum
and perform global and local search processes in a balanced manner, due to the selection strategies and neighbor
production mechanisms used. Moreover, ABC has fewer control parameters (colony size, maximum cycle, and
limit) than PSO and GA, which are independent from complexity or problem type [23,24].

3. Control method
3.1. General structure of the fuzzy-PID controller
The block diagram of the optimized Mamdani-type fuzzy-PID controller for the regulation of the BGC of the
virtual patient is presented in Figure 2. The system is designed based on a Mamdani-type fuzzy architecture.
The error signal ( e) and its rate of change (ec ) are the input variables. The insulin infusion rate (u) is the
output variable. The error signal (e) represents the diﬀerence between the measured BGC of the virtual patient
under the control system and the set point value, i.e. 110 mg/dL. The MFs of the Mamdani-type fuzzy controller
comprise three and five linguistic variables for input and output, respectively. Gaussian MFs are used for all
linguistic variables. Each function has the following form:

Figure 2. Block diagram of the optimized fuzzy-PID controller.

(
µ (z) = exp

(z − c)
2σ

2

)
,

(9)
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where the parameters σ and c are the variance and the mean of each MF, respectively. Parameter z represents
the crisp input, and µ(z) is its MF degree in the interval [0 1]. Table 2 shows the meanings of all linguistic
variables. A total of nine IF-THEN rules are demonstrated in Table 3.
Table 2. Meaning of input and output membership functions.

Label
E-N
E-Z
E-P
EC-N
EC-Z
EC-P
NM
NS
Z
PS
PM

Meaning
Error negative
Error zero
Error positive
Error change negative
Error change zero
Error change positive
Negative medium
Negative small
zero
Positive small
Positive medium

Table 3. Fuzzy IF-THEN rules.

Error (e)

E-N
E-Z
E-P

Error change (ec )
EC-N EC-Z EC-P
NM
NS
Z
NS
Z
PS
Z
PS
PM

Each fuzzy rule, Ri , consists of two parts: if-part and then-part. If-part involves the input variables e
and ec , and then-part involves output variable u. In this study, the antecedent part is performed by the MIN
operator and the aggregation part is executed by the SUM operator. The output is obtained as follows:
u= (def uz∗ (f uz(X1∗ e, X2∗ ec ))),

(10)

where fuz and defuz are the fuzzification and defuzzification operations, respectively. X1 and X2 are gain
scales of the error and the error change rate, respectively. In the design of the controller, the center of gravity
defuzzifier is used. ∆Iex is the output of the fuzzy-PID controller given in Eq. (11):
∫
∆Iex = a

udt + bu

(11)

Furthermore, a saturation block is used to protect the patient’s body against extreme decrease or increase in
the injected insulin dose. The total output of the controller is expressed as follows:


 U pper,
Iex (G(t − 1)) + ∆Iex (G(t)),
Iex (G(t)) =


Lower,

Iex ≥ U pper
Lower < Iex < U pper ,

(12)

Iex ≤ Lower

where Lower and Upper are the lower and upper limits of the saturation block. Current and previous exogenous
insulin amounts at G(t) and G(t– 1) are represented by Iex (G(t)) and Iex (G(t– 1)), respectively. ∆Iex (G(t))
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provides a change in the amount of insulin injection depending on BGC. The proposed controller operates in
the range of [Lower, Upper ] mU/min. The total amount of insulin at t = 0 is obtained as follows:
Iex (G(0)) = ∆Iex (G(0)) + init,

(13)

where init is the injected amount of insulin from the insulin pump at t = 0, which plays an important role in
mimicking the reference model at the beginning of the simulation.
3.2. Optimization of the controller by ABC
The ABC algorithm is used for determining the parameters by minimizing an objective function. The diﬀerence
between the amount of BGC of the reference model (BGC ref ) and the BGC of the virtual patient (BGC f uzzy ),
i.e. output of the controlled glucose–insulin system, is considered as an error. Based on this, the mean absolute
percentage error (MAPE), as given by Eq. (14), is used as the objective function for the optimization process.
The aim of ABC is to minimize the MAPE as in [17,18,25].
1 ∑ BGCref − BGCf uzzy
,
n t=0
BGCref
n

M AP E =

(14)

where n is the duration of the simulation.
Optimization is performed on all the MFs described in Eq. (9) and the weighting parameters, i.e. X1,
X2, a, and b. Additionally, the parameter init is optimized for choosing the optimal amount of the injected
insulin at the beginning of the simulation. Moreover, the parameters Upper and Lower are determined by the
ABC algorithm. The control parameter values of ABC are given as follows: Colony size is 60, maximum cycle
is 100, and Limit is 870. Matlab/Optimization Toolbox is used for the optimization process.
In order to obtain minimum MAPE value, the ABC algorithm is run 30 times by using diﬀerent search
intervals. The obtained search intervals are given in Table 4.
Table 4. Search intervals.

Variables and parameters
E-N, EC-N, NM, NS
E-P, EC-P, PM, PS
E-Z, EC-Z, Z
Variance of all Gaussian MFs (σ)
Lower
Upper
X1, X2
a, b, init

Search interval
[–1 0]
[0 1]
[–0.5 0.5]
[0 1]
[0 0.45]
[0.5 2]
[0 0.5]
[0 2]

4. Simulation results
The reference model, defined in Eqs. (1)–(8), is generated via MATLAB/Simulink. In addition, the virtual
patient is obtained without using the exogenous insulin infusion rate Iin (t) , which is specified in Eq. (3).
Simulations are performed for 1440 min (24 h) to assess the controller in terms of mimicking the reference
model. In order to demonstrate the performance of the controller, two types of simulations are performed.
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4.1. Simulations without uncertainty
As mentioned before, the main purpose of the optimization process is to tune the parameters in order that
the BGC profile of the virtual patient converges to BGC profile of the reference model. After the optimization
process, the obtained MFs of the input and output linguistic variables are shown in Figures 3–5, respectively.
Table 5. Obtained parameter values.

Parameter
X1
X2
a
b
Upper (mU/min)
Lower (mU/min)
init

Value
0.1387
0.4904
0.1167
1.9594
0.9882
0.2513
0.2608

Degree of membership

1

Degree of membership

1
E−N
E−Z
E−P

0.8
0.6
0.4
0.2

EC−N
EC−Z
EC−P

0.6
0.4
0.2
0

0
−1

0.8

−0.5

0
error

0.5

1

−1

−0.5

0
error change

0.5

1

Figure 3. Obtained MFs of input 1 ( e) after optimization

Figure 4. Obtained MFs of input 2 ( ec ) after optimiza-

by ABC.

tion by ABC.

The BGC and BIC profiles of the reference model and the controlled virtual patient are presented in
Figures 6 and 7, respectively. Furthermore, the parameter values obtained with the ABC algorithm are listed
in Table 5. Finally, the performance comparison of the proposed controller and similar studies in the literature
are given in Table 6.
Table 6. Comparison of the studies in terms of performance analysis.

Proposed controller
SOTFC in [18]
Controller in [17]
Controller in [25]
Reference model

Objective function
value (%)
0.7822
1.235
1.3787
1.4136
-

Mean value of the BGC
(mg.dL−1 .min−1 )
106.11
104.6055
106.3488
107.38

Daily infusion
(mU/day)
695.75
707.595
708.8412
708.1953
705.25

It should be emphasized that the obtained simulation results are more successful than those obtained in
[17], [18], and [25]. The controller has several advantages and superiority over the mentioned studies, which are
summarized below:
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Blood glucose concentration (mg/dL)
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Degree of membership

1
0.8

NM
NS
Z
PS
PM

0.6
0.4
0.2
0
−1

−0.5

0
insulin infusion rate

0.5

1

Figure 5. Obtained MFs of output ( u) after optimization
by ABC.
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Figure 6. BGC profiles of the reference model and the
controlled virtual patient.

Blood insulin concentration (µU/mL)

30
reference
controlled virtual patient

25

20

15

0

200

400

600
800
Time (min)

1000

1200

1400

Figure 7. BIC profiles of the reference model and the controlled virtual patient.

i) The proposed controller satisfies the design requirements with only 9 rules. In [17] and [25], however, 49
rules are defined. In [18], the swarm optimization-tuned Mamdani fuzzy controller (SOTFC) also has 9
rules.
ii) As seen in Table 6, the objective function value is only 0.7822%. In [17], the best value for the objective
function is 1.3787%. In [25], it is 1.4136%, and in [18], it is 1.235%.
iii) The proposed controller performed the control function with the minimum insulin infusion. Particularly
during the first hours of the simulation, the controller provides less insulin than the reference model.
Given the entire duration of the simulation, it can be said that the controller is starting to follow the
glucose oscillation of the reference model earlier. Figures 6 and 7 clearly demonstrate this situation.
4.2. Robustness tests of the controller
To show the robustness of the controller, three diﬀerent tests are implemented: 1) unusual glucose intake, 2)
sensor noise, and 3) uncertainty in the clearance rate parameter. As mentioned before, the normoglycemic
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range of BGC is considered as 70–180 mg/dL. In each case, the results are compared in a similar way to the
simulations without uncertainty.
4.2.1. Unusual glucose intake
Normally, the highest rate of glucose intake is 5 (mg/dL)/min. In this case, a value equal to 15 (mg/dL)/min
glucose is added to the model at a time interval between 735 and 740 min. The amount considered here is 5
(mg/dL)/min larger than the amount in [17], [18], and [25] for the same situation. The total absorbed glucose
intake can reach 20 (mg/dL)/min with this unexpected glucose absorption. The highest recorded BGC within
the time interval of applying the disturbance is only 121.2 mg/dL. On the other hand, the obtained highest
BGC values for the same situation are 130.9063 mg/dL in [18], 126.7097 mg/dL in [17], and approximately 131
mg/dL in [25]. Figure 8 demonstrates a satisfactory performance of the proposed controller in this case.
4.2.2. Sensor noise
A white Gaussian noise with a mean equal to 0 and variance equal to 0.3 is assumed as the eﬀect of measurement
noise, which is more severe than the conditions given in [17,18,25]. BGC profiles in the presence of sensor noise
are demonstrated in Figure 9. As shown in Figure 9, the controller gives highly eﬀective results in dealing
with sensor noise. Obtained BGC by the controller is in the range of 93.87–118.75 mg/dL. Consequently, these
results are promising in terms of practical applications such as an insulin pump, by means of the eﬃcacious
performance of the proposed controller.
4.2.3. Uncertainty in the clearance rate parameter
In real life, insulin absorption varies from patient to patient. To simulate this situation, the clearance rate
parameter given in Eq. (2), di , is assumed to be uncertain. The nominal value of di is 0.0076. If di is
decreased, the insulin degradation rate decreases; in other words, less external infused insulin is required to
150
reference
controlled virtual patient
reference
controlled virtual patient

140

125

130
110
720

120

760

110
100
90

0

200

400

600
800
Time (min)

1000

1200

1400

Figure 8. BGC profiles of the reference model and the
controlled virtual patient in the presence of unusual glucose intake.
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Figure 9. BGC profiles of the reference model and the
controlled virtual patient in the presence of sensor noise.
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keep BGC in the normoglycemic range and vice versa. The BGC profiles obtained under this condition are
shown in Figures 10 and 11. A comparative list of the amounts of insulin injected via the insulin pump is shown
in Table 7. As in [17,18,25], it is assumed that the parameter di is changed by ±20%:

Blood glucose concentration (mg/dL)

reference
controlled virtual patient

120
110
100
90
80
70
60

Blood glucose concentration (mg/dL)
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130

140
130
120
110
100
90

0

200

400

600
800
Time (min)

1000

1200

1400

Figure 10. BGC profiles of the reference model and the
controlled virtual patient when the clearance rate parameter di = di LOWER.

reference
controlled virtual patient

0

200

400

600
800
Time (min)

1000

1200

1400

Figure 11. BGC profiles of the reference model and the
controlled virtual patient when the clearance rate parameter di = di UPPER.

di LOW ER = 0.8di

(15)

di U P P ER = 1.2di

(16)

When di LOWER is used, BIC degrades slowly. This means that the patient is faced with a reduced BGC.
Nearly 2 h after beginning the simulation, the BIC profiles of the virtual patient and the reference model are
in the range of [15.55 22.16] µ U/mL and [20.63 30.72] µ U/mL, respectively. Moreover, the BGC profiles of
the virtual patient and the reference model are in the range of [84.79 95.91] mg/dL and [74.56 84.85] mg/dL,
respectively.
Table 7. Injected insulin amounts in the presence of uncertainty in the clearance rate.

Proposed controller
SOTFC in [18]
Controller in [17]
Controller in [25]

When di = di LOWER
(mU/day)
467.7585
597.8805
601.2317
599.5973

When di = di UPPER
(mU/day)
723.5896
826.9351
832.345
833.381

When di UPPER is used, BIC degrades fast. The patients with di UPPER will face increased BGC, i.e.
hyperglycemia. About 2 h after the beginning of the simulation, BGC reached the range of [104.56 126.47]
mg/dL for the virtual patient, which is in the normoglycemic range. The BIC values of the virtual patient are
similarly in the range of [13.85 21.61] µ U/mL.
5. Conclusion
In this study, a closed-loop control system, based on the Mamdani-type fuzzy controller, is proposed to imitate
the glucose profile of the healthy person. On the basis of the controller, the ABC optimization algorithm
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is employed to obtain optimal parameters for input and output MFs, and weighting parameters through the
objective function. Numerical simulations cover 24-h daily life and include robustness tests such as unusual
glucose intake, sensor noise, and uncertainty in the clearance rate parameter. As can be clearly seen from
Tables 6 and 7, the proposed controller has the lowest objective function value among the mentioned studies,
and performed the control function with the minimum insulin infusion. It is revealed from the numerical results
that the proposed controller outperforms the compared studies and is able to keep BGC in the normoglycemic
range. Future works may include testing the proposed controller on more rigorous models that contain entire
dynamics of real patients with T1DM.
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